Options
PLD3 in non-familial Alzheimer's disease
ISSN
0028-0836
Date Issued
2015
Author(s)
Heilmann, Stefanie
Drichel, Dmitriy
Clarimon, Jordi
Fernández, Victoria
Lacour, André
Wagner, Holger
Thelen, Mathias
Hernández, Isabel
Fortea, Juan
Alegret, Montserrat
Blesa, Rafael
Mauleón, Ana
Roca, Maitée Rosende
Peters, Oliver
Heun, Reinhard
Frölich, Lutz
Hüll, Michael
Heneka, Michael T.
Riedel-Heller, Steffi
Scherer, Martin
Jessen, Frank
Becker, Tim
Tárraga, Lluís
Boada, Mercè
Maier, Wolfgang
Lleó, Alberto
Ruiz, Agustin
Nöthen, Markus M.
Ramirez, Alfredo
DOI
10.1038/nature14039
Abstract
Interest in the role of rare genetic variants in the aetiology of complex diseases such as Alzheimer's disease is increasing1,2. Recently, Cruchaga et al.3 provided evidence supporting the role of rare variants in the phospholipase D3 (PLD3) gene in both familial late-onset Alzheimer's disease (age at onset >65 years) and in non-familial Alzheimer's disease. In a follow-up study of 3,568 non-familial Alzheimer's disease cases and 3,867 controls of German or Spanish descent, we failed to replicate the latter finding. Our results therefore cast doubt on the aetiological relevance of rare coding PLD3 variants in non-familial Alzheimer's disease.